Human Diabetic Primary Cardiac Fibroblast Cells
Quick Actions
Product Overview
Description
Human Diabetic Primary Cardiac Fibroblast Cells are specialized cell lines derived from human cardiac tissue affected by diabetes. These cells play a crucial role in understanding the mechanisms of cardiac fibrosis and related heart conditions in diabetic patients.
They are essential for research on diabetic cardiomyopathy, as well as for testing potential therapeutic interventions aimed at improving heart health in individuals with diabetes.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPDF003
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RU0)
Characterization Markers
- Characterized by spindle morphology under light microscopy.
- Negative for von Willebrand Factor (vWF) , Cytokeratin 18,
and alpha-smooth muscle actin .
- Isolated and characterized to ensure fibroblast purity and identity.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
